Prescription Pharmacy | Online Pharmacy Prescription | Internet Pharmacies Prescription
www.onlinepharmacyrx.org
- US Toll free:
- Regular US:
- UK:
- Categories list
-
- Alcoholism
- Alzheimer's And Parkinson's
- Analgesics
- Anti-inflammatories
- Antiallergic
- Antibiotics
- Anticonvulsants
- Antidepressants
- Antifungals
- Antiparasitic
- Antivirals
- Arthritis
- Asthma
- Birth Control
- Cancer
- Cardiovascular Diseases
- Cholesterol
- Diabetes
- Diuretics
- Erectile Dysfunction
- Eye Care
- Gastrointestinal Tract
- HIV
- Hypertension
- Men's Health
- Mental Disorders
- Migraine
- Muscle Relaxants
- Neurological Disorders
- Obesity
- Osteoporosis
- Respiratory Tract
- Skin Care
- Surgery
- Urinary Tract
- Women's Health
Generic Atomoxetine - Strattera, Eldepryl, Luvox, Paxil
Generic Strattera
Generic Strattera is used for treating ADHD (attention-deficit hyperactivity disorder).
$0.78
Buy now!
Generic Eldepryl
Generic Eldepryl is used for treating Parkinson disease. This medicine is taken with levodopa-carbidopa medicines.
$0.90
Buy now!
$1.29
Buy now!
Generic Paxil
Treating depression, obsessive-compulsive disorder (OCD), generalized and social anxiety disorders...
$0.85
Buy now!
Choose Your language:
- Testimonials
-
I appreciate your personalized customer service and prompt follow up. All I can say is this, if you are this straight forward and direct when something goes wrong, then you treat your customers with respect. And if you do that on a regular basis, you deserve to have great things happen to you in the future.
Read more »
I will be in touch.
Thanks.
- News
-
- FDA approved Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
- Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years
- The forming, development and monitoring of the pharmaceutical market in USA in September 2011
- In spite of low rates and stagnation of industrial development, the pharmaceutical market shows a dynamical growth
- Sildenafil citrate and pulmonary arterial hypertension
- Pulmonary arterial hypertension Definition “pulmonary arterial hypertension” is related to a group of diseases characterized by: - Progressive increase in pulmonary vascular resistance; - Reduction in pulmonary bloodflow; - High pulmonary artery pressure; - Contractility of the heart right ventricle; - Right ventricular failure
- Fruit and vegetables do not reduce overall cancer risk, review concludes
- Eating lots of fruit and vegetables will do little to reduce your risk of developing cancer, according to a review of a decade of research involving more than a million people
- Common painkillers could be linked to male reproductive disorder
- The use of mild painkillers, such as paracetamol, in pregnancy – previously considered harmless to the baby in the womb – could be a major factor in the rise of male reproductive disorders, according to a study
-
- Long-term benefits of ADHD drugs in kids are uncertain - ConsumerReports.org (blog)
- Long-term benefits of ADHD drugs in kids are uncertainConsumerReports
- Retail prices of 1000 medicines to fall under new reimbursement list - Pharma Poland News (subscription)
- Pharma Poland News (subscription)Retail prices of 1000 medicines to fall under new reimbursement listPharma Poland News (subscription)Also, it again includes atomoxetine as indicated for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children aged six and older and teens
- 不專心坐不住 恐患注意力不足過動症 - yam天空新聞
- 不專心坐不住 恐患注意力不足過動症yam天空新聞根據衛生署指出，目前核准用以治療ADHD的藥物是（一）中樞神經興奮劑：Methylphenidate，MPH（短效型MPH，Ritalin；長效型MPH，Concerta），國際上已使用於治療ADHD超過50年了，衛生署也核准MPH治療ADHD長達數十年了；（二）非中樞神經興奮劑：Atomoxetine（思銳）。and more »
 |
Bookmark this site |
|---|
 |
Subscribe to the News |
|---|
